rs201921014
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 1P and 9B. PP2BP4_StrongBP6BS2
The NM_015271.5(TRIM2):c.2197A>G(p.Ile733Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00017 in 1,613,610 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_015271.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRIM2 | NM_015271.5 | c.2197A>G | p.Ile733Val | missense_variant | 12/12 | ENST00000338700.10 | NP_056086.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRIM2 | ENST00000338700.10 | c.2197A>G | p.Ile733Val | missense_variant | 12/12 | 1 | NM_015271.5 | ENSP00000339659 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152234Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000251 AC: 63AN: 250970Hom.: 1 AF XY: 0.000280 AC XY: 38AN XY: 135628
GnomAD4 exome AF: 0.000172 AC: 251AN: 1461258Hom.: 2 Cov.: 29 AF XY: 0.000190 AC XY: 138AN XY: 726940
GnomAD4 genome AF: 0.000151 AC: 23AN: 152352Hom.: 0 Cov.: 32 AF XY: 0.000174 AC XY: 13AN XY: 74506
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 29, 2021 | The c.2197A>G (p.I733V) alteration is located in exon 12 (coding exon 12) of the TRIM2 gene. This alteration results from a A to G substitution at nucleotide position 2197, causing the isoleucine (I) at amino acid position 733 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Charcot-Marie-Tooth disease type 2R Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 17, 2023 | This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 706 of the TRIM2 protein (p.Ile706Val). This variant is present in population databases (rs201921014, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with TRIM2-related conditions. ClinVar contains an entry for this variant (Variation ID: 474608). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 11, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at